Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment
Restricted accessResearch articleFirst published online September, 2016
Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment
Due to the limitations of research using human embryos and the lack of a biological model of human liver development, the roles of the various markers associated with liver stem or progenitor cell potential in humans are largely speculative, and based on studies utilizing animal models and certain patient tissues. Human pluripotent stem cell-based in vitro multistage hepatic differentiation systems may serve as good surrogate models for mimicking normal human liver development, pathogenesis and injury/regeneration studies. Here, we describe the implications of various liver stem or progenitor cell markers and their bipotency (i.e. hepatocytic- and biliary-epithelial cell differentiation), based on the pluripotent stem cell-derived model of human liver development. Future studies using the human cellular model(s) of liver and biliary development will provide more human relevant biological and/or pathological roles of distinct markers expressed in heterogeneous liver stem/progenitor cell populations.
ChoiSMKimYLiuHChaudhariPYeZJangYY. Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle2011; 10: 2423–7.
2.
ChoiSMKimYShimJSParkJTWangRHLeachSDLiuJODengCYeZJangYY. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology2013; 57: 2458–68.
3.
ChoiSMLiuHChaudhariPKimYChengLFengJSharkisSYeZJangYY. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood2011; 118: 1801–5.
4.
ChunYSChaudhariPJangYY. Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int J Biol Sci2010; 6: 796–805.
5.
FanJRobertCJangYYLiuHSharkisSBaylinSBRassoolFV. Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining. Mutat Res2011; 713: 8–17.
LiuHKimYSharkisSMarchionniLJangYY. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med2011; 3: 82ra39–82ra39.
8.
LiuHYeZKimYSharkisSJangYY. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology2010; 51: 1810–9.
9.
SharkisSJJonesRJCivinCJangYY. Pluripotent stem cell-based cancer therapy: promise and challenges. Sci Transl Med2012; 4: 127ps9–127ps9.
10.
SmithCAbalde-AtristainLHeCBrodskyBRBraunsteinEMChaudhariPJangYYChengLYeZ. Efficient and allele-specific genome editing of disease loci in human iPSCs. Mol Ther2015; 23: 570–7.
11.
JungJZhengMGoldfarbMZaretKS. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science1999; 284: 1998–2003.
12.
DouarinNM. An experimental analysis of liver development. Med Biol1975; 53: 427–55.
13.
Fukuda-TairaS. Hepatic induction in the avian embryo: specificity of reactive endoderm and inductive mesoderm. J Embryol Exp Morphol1981; 63: 111–25.
14.
RossiJMDunnNRHoganBLZaretKS. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev2001; 15: 1998–2009.
15.
WattAJBattleMALiJDuncanSA. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci USA2004; 101: 12573–8.
16.
WattAJZhaoRLiJDuncanSA. Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev Biol2007; 7: 37–37.
17.
NemerGNemerM. Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6. Dev Biol2003; 254: 131–48.
18.
BortRMartinez-BarberaJPBeddingtonRSZaretKS. Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development2004; 131: 797–806.
19.
McLinVARankinSAZornAM. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development2007; 134: 2207–17.
20.
GoesslingWNorthTELordAMCeolCLeeSWeidingerGBourqueCStrijboschRHaramisAPPuderMCleversHMoonRTZonLI. APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev Biol2008; 320: 161–74.
LeeCSFriedmanJRFulmerJTKaestnerKH. The initiation of liver development is dependent on Foxa transcription factors. Nature2005; 435: 944–7.
23.
LiZWhitePTutejaGRubinsNSackettSKaestnerKH. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest2009; 119: 1537–45.
24.
TurnerRLozoyaOWangYCardinaleVGaudioEAlpiniGMendelGWauthierEBarbierCAlvaroDReidLM. Human hepatic stem cell and maturational liver lineage biology. Hepatology2011; 53: 1035–45.
25.
SchmelzerEWauthierEReidLM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells2006; 24: 1852–8.
26.
SchmelzerEZhangLBruceAWauthierELudlowJYaoHLMossNMelhemAMcClellandRTurnerWKulikMSherwoodSTallhedenTChengNFurthMEReidLM. Human hepatic stem cells from fetal and postnatal donors. J Exp Med2007; 204: 1973–87.
27.
WangYCuiCBYamauchiMMiguezPRoachMMalavarcaRCostelloMJCardinaleVWauthierEBarbierCGerberDAAlvaroDReidLM. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology2011; 53: 293–305.
28.
SaxenaRTheiseN. Canals of Hering: recent insights and current knowledge. Semin Liver Dis2004; 24: 43–8.
29.
TurnerWSSchmelzerEMcClellandRWauthierEChenWReidLM. Human hepatoblast phenotype maintained by hyaluronan hydrogels. J Biomed Mater Res B Appl Biomater2007; 82: 156–68.
30.
AbelevGI. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res1971; 14: 295–358.
31.
HarunaYSaitoKSpauldingSNalesnikMAGerberMA. Identification of bipotential progenitor cells in human liver development. Hepatology1996; 23: 476–81.
32.
DessimozJOpokaRKordichJJGrapin-BottonAWellsJM. FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo. Mech Dev2006; 123: 42–55.
33.
BergTRountreeCBLeeLEstradaJSalaFGChoeAVeltmaatJMDe LangheSLeeRTsukamotoHCrooksGMBellusciSWangKS. Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology2007; 46: 1187–97.
34.
MatsumotoKMikiRNakayamaMTatsumiNYokouchiY. Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. Dev Biol2008; 319: 234–47.
35.
OnitsukaITanakaMMiyajimaA. Characterization and functional analyses of hepatic mesothelial cells in mouse liver development. Gastroenterology2010; 138: 1525–35, 35 e1–6.
36.
KamiyaAKinoshitaTItoYMatsuiTMorikawaYSenbaENakashimaKTagaTYoshidaKKishimotoTMiyajimaA. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J1999; 18: 2127–36.
37.
ChaudhariPPrasadNTianLJangYY. Determination of functional activity of human iPSC-derived hepatocytes by measurement of CYP metabolism. Methods Mol Biol2016; 1357: 383–94.
38.
TakayamaKInamuraMKawabataKKatayamaKHiguchiMTashiroKNonakaASakuraiFHayakawaTFurueMKMizuguchiH. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol Ther2012; 20: 127–37.
39.
ShanJSchwartzRERossNTLoganDJThomasDDuncanSANorthTEGoesslingWCarpenterAEBhatiaSN. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol2013; 9: 514–20.
40.
CardinaleVWangYCarpinoGCuiCBGattoMRossiMBerlocoPBCantaforaAWauthierEFurthMEInverardiLDominguez-BendalaJRicordiCGerberDGaudioEAlvaroDReidL. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology2011; 54: 2159–72.
41.
NowakGEriczonBGNavaSJakschMWestgrenMSumitran-HolgerssonS. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut2005; 54: 972–9.
42.
HiguchiYKawaiKYamazakiHNakamuraMBreeFGuguen-GuillouzoCSuemizuH. The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice. Xenobiotica2014; 44: 146–53.
43.
DeurholtTvan TilNPChhattaAAten BloemendaalLSchwartlanderRPayneCPlevrisJNSauerIMChamuleauRAElferinkRPSeppenJHoekstraR. Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol2009; 9: 89–89.
44.
CerecVGlaiseDGarnierDMorosanSTurlinBDrenouBGriponPKremsdorfDGuguen-GuillouzoCCorluA. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology2007; 45: 957–67.
45.
SnykersSDe KockJTamaraVRogiersV. Hepatic differentiation of mesenchymal stem cells: in vitro strategies. Methods Mol Biol2011; 698: 305–14.
AntoniouARaynaudPCordiSZongYTroncheFStangerBZJacqueminPPierreuxCEClotmanFLemaigreFP. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology2009; 136: 2325–33.
48.
OikawaTKamiyaAZeniyaMChikadaHHyuckADYamazakiYWauthierETajiriHMillerLDWangXWReidLMNakauchiH. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology2013; 57: 1469–83.
49.
TakayamaKNagamotoYMimuraNTashiroKSakuraiFTachibanaMHayakawaTKawabataKMizuguchiH. Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishes. Stem Cell Rep2013; 1: 322–35.
50.
DianatNDubois-Pot-SchneiderHSteichenCDesterkeCLeclercPRaveuxACombettesLWeberACorluADubart-KupperschmittA. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology2014; 60: 700–14.
51.
OgawaMOgawaSBearCEAhmadiSChinSLiBGrompeMKellerGKamathBMGhanekarA. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat Biotechnol2015; 33: 853–61.
52.
SampaziotisFCardoso de BritoMMadrigalPBerteroASaeb-ParsyKSoaresFASchrumpfEMelumEKarlsenTHBradleyJAGelsonWTDaviesSBakerAKaserAAlexanderGJHannanNRVallierL. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol2015; 33: 845–52.
53.
ZhaoDChenSCaiJGuoYSongZCheJLiuCWuCDingMDengH. Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS One2009; 4: e6468–e6468.
54.
TianLDeshmukhAYeZJangYY. Efficient and controlled generation of 2D and 3D bile duct tissue from human pluripotent stem cell-derived spheroids. Stem Cell Rev Rep2016. DOI:10.1007/s12015-016-9657–5.
55.
BrilliantKEMillsDRCallananHMHixsonDC. Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C. Transplantation2009; 88: 486–95.
56.
KrausePRave-FrankMWolffHABeckerHChristiansenHKoenigS. Liver sinusoidal endothelial and biliary cell repopulation following irradiation and partial hepatectomy. World J Gastroenterol2010; 16: 3928–35.
57.
YuBHeZYYouPHanQWXiangDChenFWangMJLiuCCLinXWBorjiginUZiXYLiJXZhuHYLiWLHanCSWangensteenKJShiYHuiLJWangXHuYP. Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell2013; 13: 328–40.
58.
BortRSignoreMTremblayKMartinez BarberaJPZaretKS. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol2006; 290: 44–56.
59.
MargagliottiSClotmanFPierreuxCEBeaudryJBJacqueminPRousseauGGLemaigreFP. The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol2007; 311: 579–89.
60.
Sosa-PinedaBWigleJTOliverG. Hepatocyte migration during liver development requires Prox1. Nat Genet2000; 25: 254–5.
61.
DorrellCGrompeM. Liver repair by intra- and extrahepatic progenitors. Stem Cell Rev2005; 1: 61–4.
62.
FaustoNCampbellJS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev2003; 120: 117–30.
63.
LemireJMShiojiriNFaustoN. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol1991; 139: 535–52.
64.
TeeLBKirilakYHuangWHMorganRHYeohGC. Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. Carcinogenesis1994; 15: 2747–56.
65.
TianYWSmithPGYeohGC. The oval-shaped cell as a candidate for a liver stem cell in embryonic, neonatal and precancerous liver: identification based on morphology and immunohistochemical staining for albumin and pyruvate kinase isoenzyme expression. Histochem Cell Biol1997; 107: 243–50.
66.
OkabeMTsukaharaYTanakaMSuzukiKSaitoSKamiyaYTsujimuraTNakamuraKMiyajimaA. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development2009; 136: 1951–60.
67.
SackettSDLiZHurttRGaoYWellsRGBrondellKKaestnerKHGreenbaumLE. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology2009; 49: 920–9.
68.
BrownLFBerseBVan de WaterLPapadopoulos-SergiouAPerruzziCAManseauEJDvorakHFSengerDR. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell1992; 3: 1169–80.
69.
KawashimaRMochidaSMatsuiAYouLuTuZYIshikawaKToshimaKYamanobeFInaoMIkedaHOhnoANagoshiSUedeTFujiwaraK. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun1999; 256: 527–31.
70.
WangYMochidaSKawashimaRInaoMMatsuiAYouLuTuZYNagoshiSUedeTFujiwaraK. Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. Journal of gastroenterology2000; 35: 696–701.
71.
LorenaDDarbyIAGadeauAPLeenLLRittlingSPortoLCRosenbaumJDesmouliereA. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice. J Hepatol2006; 44: 383–90.
72.
DeLaForestANagaokaMSi-TayebKNotoFKKonopkaGBattleMADuncanSA. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development2011; 138: 4143–53.
73.
Torres-PadillaMEFougere-DeschatretteCWeissMC. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3′ end splicing. Mech Dev2001; 109: 183–93.
ChenWSManovaKWeinsteinDCDuncanSAPlumpASPreziosoVRBachvarovaRFDarnellJEJr. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev1994; 8: 2466–77.
76.
DuncanSAManovaKChenWSHoodlessPWeinsteinDCBachvarovaRFDarnellJEJr. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc Natl Acad Sci USA1994; 91: 7598–602.
77.
LiKZhangHWangYWangYFengM. Differential expression of HNF4alpha isoforms in liver stem cells and hepatocytes. J Cell Biochem2006; 99: 558–64.
78.
BattleMAKonopkaGParvizFGagglALYangCSladekFMDuncanSA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA2006; 103: 8419–24.
79.
BolotinELiaoHTaTCYangCHwang-VersluesWEvansJRJiangTSladekFM. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology2010; 51: 642–53.
80.
KuoCJConleyPBChenLSladekFMDarnellJEJrCrabtreeGR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature1992; 355: 457–61.
81.
KyrmiziIHatzisPKatrakiliNTroncheFGonzalezFJTalianidisI. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev2006; 20: 2293–305.
82.
GonzalezFJ. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet2008; 23: 2–7.
83.
HayhurstGPLeeYHLambertGWardJMGonzalezFJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol2001; 21: 1393–403.
84.
MaestroMACardaldaCBojSFLucoRFServitjaJMFerrerJ. Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth. Endocr Dev2007; 12: 33–45.
85.
ShahjalalHMShirakiNSakanoDKikawaKOgakiSBabaHKumeKKumeS. Generation of insulin-producing beta-like cells from human iPS cells in a defined and completely xeno-free culture system. J Mol Cell Biol2014; 6: 394–408.
86.
LitvinovSVBakkerHAGourevitchMMVeldersMPWarnaarSO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun1994; 2: 417–28.
MunzMKieuCMackBSchmittBZeidlerRGiresO. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene2004; 23: 5748–58.
89.
GonzalezBDenzelSMackBConradMGiresO. EpCAM is involved in maintenance of the murine embryonic stem cell phenotype. Stem Cells2009; 27: 1782–91.
90.
SankpalNVWillmanMWFlemingTPMayfieldJDGillandersWE. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res2009; 69: 753–7.
91.
Chaves-PerezAMackBMaetzelDKremlingHEggertCHarreusUGiresO. EpCAM regulates cell cycle progression via control of cyclin D1 expression. Oncogene2013; 32: 641–50.
92.
YoonSMGerasimidouDKuwaharaRHytiroglouPYooJEParkYNTheiseND. Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology2011; 53: 964–73.
93.
GiresO. EpCAM in hepatocytes and their progenitors. J Hepatol2012; 56: 490–2.
94.
ZhangLTheiseNChuaMReidLM. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology2008; 48: 1598–607.
95.
YovchevMIGrozdanovPNZhouHRacherlaHGuhaCDabevaMD. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology2008; 47: 636–47.
96.
de BoerCJvan KriekenJHJanssen-van RhijnCMLitvinovSV. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol1999; 188: 201–6.
97.
NgVYAngSNChanJXChooAB. Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells. Stem Cells2010; 28: 29–35.
SpearBTJinLRamasamySDobierzewskaA. Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell Mol Life Sci2006; 63: 2922–38.
100.
MorfordLADavisCJinLDobierzewskaAPetersonMLSpearBT. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2. Hepatology2007; 46: 1541–7.
101.
PerincheriSDingleRWPetersonMLSpearBT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc Natl Acad Sci USA2005; 102: 396–401.
102.
XieZZhangHTsaiWZhangYDuYZhongJSzpirerCZhuMCaoXBartonMCGrusbyMJZhangWJ. Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci USA2008; 105: 10859–64.
103.
ShiojiriN. Enzymo- and immunocytochemical analyses of the differentiation of liver cells in the prenatal mouse. J Embryol Exp Morphol1981; 62: 139–52.
104.
HuaMZhangWLiWLiXLiuBLuXZhangH. Molecular mechanisms regulating the establishment of hepatocyte polarity during human hepatic progenitor cell differentiation into a functional hepatocyte-like phenotype. J Cell Sci2012; 125: 5800–10.
105.
WangPZhangHLiWZhaoYAnW. Promoter-defined isolation and identification of hepatic progenitor cells from the human fetal liver. Histochem Cell Biol2008; 130: 375–85.
106.
ArrietaOCachoBMorales-EspinosaDRuelas-VillavicencioAFlores-EstradaDHernandez-PedroN. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer2007; 7: 28–28.
107.
FarinatiFMarinoDDe GiorgioMBaldanACantariniMCursaroCRapacciniGDel PoggioPDi NolfoMABenvegnuLZoliMBorzioFBernardiMTrevisaniF. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Am J Gastroenterol2006; 101: 524–32.
108.
BruixJShermanM. Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology2005; 42: 1208–36.
109.
YinAHMiragliaSZanjaniEDAlmeida-PoradaGOgawaMLearyAGOlweusJKearneyJBuckDW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood1997; 90: 5002–12.
110.
SinghSKClarkeIDTerasakiMBonnVEHawkinsCSquireJDirksPB. Identification of a cancer stem cell in human brain tumors. Cancer Res2003; 63: 5821–8.
111.
BrunoSBussolatiBGrangeCCollinoFGrazianoMEFerrandoUCamussiG. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol2006; 169: 2223–35.
112.
RountreeCBDingWHeLStilesB. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells2009; 27: 290–9.
113.
O’BrienCAPollettAGallingerSDickJE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature2007; 445: 106–10.
114.
CollinsATBerryPAHydeCStowerMJMaitlandNJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res2005; 65: 10946–51.
115.
RountreeCBBarskyLGeSZhuJSenadheeraSCrooksGM. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells2007; 25: 2419–29.
116.
KordesCSawitzaIMuller-MarbachAAle-AghaNKeitelVKlonowski-StumpeHHaussingerD. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun2007; 352: 410–7.
117.
MavilaNJamesDShivakumarPNguyenMVUtleySMakKWuAZhouSWangLVendyresCGroffMAsahinaKWangKS. Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology2014; 60: 941–53.
118.
Van EykenPSciotRCalleaFVan der SteenKMoermanPDesmetVJ. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology1988; 8: 1586–95.
119.
del CastilloGAlvarez-BarrientosACarmona-CuencaIFernandezMSanchezAFabregatI. Isolation and characterization of a putative liver progenitor population after treatment of fetal rat hepatocytes with TGF-beta. J Cell Physiol2008; 215: 846–55.
120.
RoskamsTDe VosRVan EykenPMyazakiHVan DammeBDesmetV. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol1998; 29: 455–63.
121.
MatsukumaSTakeoHKonoTNagataYSatoK. Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study. Histopathology2012; 61: 857–62.
122.
Van EykenPSciotRDesmetVJ. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express ‘bile duct-type’ cytokeratins. Histopathology1988; 13: 605–17.
123.
FuruyamaKKawaguchiYAkiyamaHHoriguchiMKodamaSKuharaTHosokawaSElbahrawyASoedaTKoizumiMMasuiTKawaguchiMTakaoriKDoiRNishiEKakinokiRDengJMBehringerRRNakamuraTUemotoS. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet2011; 43: 34–41.
124.
MichelottiGATuckerASwiderska-SynMMachadoMVChoiSSKrugerLSoderblomEThompsonJWMayer-SalmanMHimburgHAMoylanCAGuyCDGarmanKSPremontRTChuteJPDiehlAM. Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches. Gut2016; 65: 683–692.
125.
MoylanCAPangHDellingerASuzukiAGarrettMEGuyCDMurphySKAshley-KochAEChoiSSMichelottiGAHamptonDDChenYTillmannHLHauserMAAbdelmalekMFDiehlAM. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology2014; 59: 471–82.
MichelottiGAXieGSwiderskaMChoiSSKaracaGKrugerLPremontRYangLSynWKMetzgerDDiehlAM. Smoothened is a master regulator of adult liver repair. J Clin Invest2013; 123: 2380–94.
128.
PritchettJHarveyEAthwalVBerryARoweCOakleyFMolesAMannDABobolaNSharrocksADThomsonBJZaitounAMIrvingWLGuhaINHanleyNAHanleyKP. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology2012; 56: 1108–16.
129.
CarpentierRSunerREvan HulNKoppJLBeaudryJBCordiSAntoniouARaynaudPLepreuxSJacqueminPLeclercqIASanderMLemaigreFP. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology2011; 141: 1432–8, 8 e1–4.
130.
HanleyKPOakleyFSugdenSWilsonDIMannDAHanleyNA. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem2008; 283: 14063–71.
131.
GuoXXiongLSunTPengRZouLZhuHZhangJLiHZhaoJ. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagn Pathol2012; 7: 44–44.
132.
Muller-RoverSPetersEJBotchkarevVAPanteleyevAPausR. Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression. J Histochem Cytochem1998; 46: 1401–10.
133.
RonnLCBerezinVBockE. The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci2000; 18: 193–9.
134.
RonnLCHartzBPBockE. The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp Gerontol1998; 33: 853–64.
135.
FabrisLStrazzaboscoMCrosbyHABallardiniGHubscherSGKellyDANeubergerJMStrainAJJoplinR. Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol2000; 156: 1599–612.
136.
RoskamsTvan den OordJJDe VosRDesmetVJ. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol1990; 137: 1019–25.
137.
DesmetVJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. Hepatology1992; 16: 1069–83.
138.
SellS. Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury. Hepatology1998; 27: 317–31.
139.
TsuchiyaALuWYWeinholdBBoulterLStutchfieldBMWilliamsMJGuestRVMinnis-LyonsSEMacKinnonACSchwarzerDIchidaTNomotoMAoyagiYGerardy-SchahnRForbesSJ. Polysialic acid/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury. Hepatology2014; 60: 1727–40.
140.
LibbrechtLCassimanDDesmetVRoskamsT. Expression of neural cell adhesion molecule in human liver development and in congenital and acquired liver diseases. Histochem Cell Biol2001; 116: 233–9.
141.
NakataniKTanakaHIkedaKSakabeMKadoyaHSekiSKanedaKNakajimaY. Expression of NCAM in activated portal fibroblasts during regeneration of the rat liver after partial hepatectomy. Arch Histol Cytol2006; 69: 61–72.
142.
StauntonDEMarlinSDStratowaCDustinMLSpringerTA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell1988; 52: 925–33.
143.
SpringerTA. Adhesion receptors of the immune system. Nature1990; 346: 425–34.
144.
MengerMDRichterSYamauchiJVollmarB. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepato-gastroenterology1999; 46(Suppl 2): 1452–7.
145.
AdamsDHHubscherSGShawJRothleinRNeubergerJM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet1989; 2: 1122–5.
146.
AdamsDHHubscherSGShawJJohnsonGDBabbsCRothleinRNeubergerJM. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology1991; 14: 426–31.
147.
VolpesRvan den OordJJDesmetVJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.
148.
VolpesRvan den OordJJDesmetVJ. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology1990; 12: 148–54.
149.
SelznerNSelznerMOdermattBTianYVan RooijenNClavienPA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology2003; 124: 692–700.
150.
KubotaHReidLM. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci USA2000; 97: 12132–7.
